10q10k10q10k.net
STRATA Skin Sciences, Inc.

STRATA Skin Sciences, Inc.SSKNEarnings & Financial Report

Nasdaq

Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.

SSKN Q3 2025 Key Financial Metrics

Revenue

$6.9M

Gross Profit

$4.2M

Operating Profit

$-1.2M

Net Profit

$-1.6M

Gross Margin

60.4%

Operating Margin

-16.9%

Net Margin

-23.4%

YoY Growth

-21.2%

EPS

$-0.36

Financial Flow

STRATA Skin Sciences, Inc. Q3 2025 Financial Summary

STRATA Skin Sciences, Inc. reported revenue of $6.9M for Q3 2025, with a net profit of $-1.6M (-23.4% margin). Cost of goods sold was $2.7M, operating expenses totaled $5.4M.

Key Financial Metrics

Total Revenue$6.9M
Net Profit$-1.6M
Gross Margin60.4%
Operating Margin-16.9%
Report PeriodQ3 2025

STRATA Skin Sciences, Inc. Annual Revenue by Year

STRATA Skin Sciences, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $33.6M).

YearAnnual Revenue
2024$33.6M
2023$33.4M
2022$36.2M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$8.7M$6.8M$8.4M$8.8M$9.6M$6.8M$7.7M$6.9M
YoY Growth-18.0%-10.7%2.2%-0.6%10.2%0.9%-9.2%-21.2%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$42.0M$40.0M$39.6M$40.2M$36.2M$34.3M$30.7M$30.7M
Liabilities$29.3M$30.6M$30.1M$30.9M$31.2M$31.6M$30.4M$29.4M
Equity$12.7M$9.4M$9.5M$9.3M$5.0M$2.7M$308000$1.3M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$1.5M$-804000$591000$-302000$703000$-550000$-1.9M$-64000